Acute pulmonary thromboembolism is associated with high mortality, similar to that of myocardial infarction and stroke. We studied the clinical presentation and management of pulmonary thromboembolism in the Indian population. An analysis of 140 patients who presented with acute pulmonary thromboembolism at a large volume center in India from June 2015 through December 2018 was performed. The mean age of our study population was 50 years with 59% being male. Comorbidities including deep vein thrombosis, diabetes mellitus, hypertension, and chronic obstructive pulmonary disease were present in 52.9%, 40%, 35.7% and 7.14% of patients, respectively. Out of 140 patients, 40 (28.6%) patients had massive pulmonary thromboembolism, 36 (25.7%) sub‐massive pulmonary thromboembolism, and 64 (45.7%) had low‐risk pulmonary thromboembolism. Overall, in‐hospital mortality was 25.7%. Multivariate regression analysis found chronic kidney disease and pulmonary thromboembolism severity to be the only independent risk factors. Thrombolysis was performed in 62.5% of patients with a massive pulmonary thromboembolism and 63.9% of patients with a sub‐massive pulmonary thromboembolism. In the massive pulmonary thromboembolism group, patients receiving thrombolytic therapy had lower mortality compared with patients who did not receive therapy (p=0.022), whereas this difference was not observed in patients in the sub‐massive pulmonary thromboembolism group. We conclude that patients with acute pulmonary thromboembolism in India presented more than a decade earlier than our western counterparts, and it was associated with poor clinical outcomes. Thrombolysis was associated with significantly reduced in‐hospital mortality in patients with massive pulmonary thromboembolism.
31 July 2026 in Catheterization and Cardiovascular Interventions
While pressure-wire based fractional flow reserve (FFR) is considered the gold standard for evaluating coronary lesion significance, its use in daily clinical practice remains limited.Angiography derived vessel based FFR (vFFR) offers a promising alternative, without the need for pressure wires or hyperaemia by leveraging three dimensional quantitative coronary angiography. This study evaluated the concordance between angiography derived vFFR and invasive FFR in patients with intermediate coronary stenosis. Retrospectively, coronary angiograms of patients who underwent adenosine based FFR from January 2022 until January 2025 for borderline lesions were retrieved from the health management information system (HMIS) software and processed by a blinded core laboratory for vFFR computation. Correlation and diagnostic performance were assessed using Mann-Whitney U testing, Spearman correlation, Bland-Altman analysis, chi-square analysis, ROC curves, and binary logistic regression. The median age of the cohort was 61 years, and 30.6% were female. LAD was the most commonly assessed artery. The median FFR and vFFR values were 0.85 and 0.83, respectively. Overall, 33.9% of lesions were classified as ischemic by FFR. A strong correlation was found between vFFR and invasive FFR (r = 0.808, p < 0.001). The diagnostic performance of vFFR was excellent with an AUC of 0.92. At a vFFR cut off of 0.80, sensitivity was 85.7% and specificity 80.5% with a diagnostic accuracy of 82.3%. Subgroup analysis demonstrated reduced correlations in bifurcation (r = 0.661) and calcified lesions (r = 0.733). In this retrospective cohort, angiography derived vFFR demonstrated good correlation and diagnostic performance compared with invasive FFR for the assessment of intermediate coronary lesions.